Entero Healthcare Solutions Limited IPO
Entero Healthcare Solutions Limited was a mainboard IPO in the Pharmacy Retail sector, offered at ₹1,195–₹1,258 per share to raise ₹1,600 crore. The issue was subscribed 1.53× overall (QIBs 2.28×, NIIs 0.22×, retail 1.33×). It listed on 16 Feb 2024 at ₹1,229 and closed its first day at ₹1,150, a listing loss of -8.6% versus the ₹1,258 issue price. It now trades around ₹1,575 (+25.2% versus the issue price).
Frequently asked questions
- How many times was the Entero Healthcare Solutions Limited IPO subscribed?
- The Entero Healthcare Solutions Limited IPO was subscribed 1.53× overall — 2.28× in the QIB category, 0.22× among non-institutional investors, 1.33× in retail.
- What were the Entero Healthcare Solutions Limited IPO listing gains?
- Entero Healthcare Solutions Limited listed on 16 Feb 2024 at ₹1,229, closing its first day at ₹1,150 — a listing loss of -8.6% versus the ₹1,258 issue price.
- What were the retail allotment odds for the Entero Healthcare Solutions Limited IPO?
- Retail was subscribed 1.33×, so a single-lot application had roughly a 75.2% chance of allotment — most applicants were allotted, and allotment was finalised on 14 Feb 2024.
- What was the price band and lot size of the Entero Healthcare Solutions Limited IPO?
- The price band was ₹1,195–₹1,258 per share, with a minimum lot of 11 shares (₹13,838 at the upper band).
- Who were the registrar and lead manager for the Entero Healthcare Solutions Limited IPO?
- Link Intime India Private Limited was the registrar, and ICICI Securities was the book-running lead manager.